| # | Drug | Count |
|---|---|---|
| 0 | BROLUCIZUMAB | 74 |
| 1 | AFLIBERCEPT | 11 |
| 2 | RANIBIZUMAB | 6 |
| 3 | MOXIFLOXACIN HYDROCHLORIDE | 5 |
| 4 | ZIDOVUDINE | 5 |
| 5 | GANCICLOVIR | 4 |
| 6 | GANCICLOVIR SODIUM | 4 |
| 7 | NEVIRAPINE | 4 |
| 8 | TRIAMCINOLONE ACETONIDE | 4 |
| 9 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROLUCIZUMAB | 74 | 0.0203 |
| 1 | SODIUM HYALURONATE | 1 | 0.0012 |
| 2 | PEGCETACOPLAN | 1 | 0.0005 |
| 3 | ZIDOVUDINE | 5 | 0.0005 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| 5 | NEVIRAPINE | 4 | 0.0004 |
| 6 | GANCICLOVIR SODIUM | 4 | 0.0004 |
| 7 | AFLIBERCEPT | 11 | 0.0004 |
| 8 | CEFTAZIDIME | 2 | 0.0003 |
| 9 | MOXIFLOXACIN HYDROCHLORIDE | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 2 | Glinide [EPC] | 1 | 0.0001 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 18 | 0.0001 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 6 | Glycopeptide Antibacterial [EPC] | 4 | 0.0001 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 4 | 0.0000 |